439 related articles for article (PubMed ID: 30291511)
1. CAIX and pax-8 Commonly Immunoreactive in Endolymphatic Sac Tumors: A Clinicopathologic Study of 26 Cases with Differential Considerations for Metastatic Renal Cell Carcinoma in von Hippel-Lindau Patients.
Thompson LDR; Magliocca KR; Andreasen S; Kiss K; Rooper L; Stelow E; Wenig BM; Bishop JA
Head Neck Pathol; 2019 Sep; 13(3):355-363. PubMed ID: 30291511
[TBL] [Abstract][Full Text] [Related]
2. Expression of renal cell markers and detection of 3p loss links endolymphatic sac tumor to renal cell carcinoma and warrants careful evaluation to avoid diagnostic pitfalls.
Jester R; Znoyko I; Garnovskaya M; Rozier JN; Kegl R; Patel S; Tran T; Abedalthagafi M; Horbinski CM; Richardson M; Wolff DJ; Lapadat R; Moore W; Rodriguez FJ; Mull J; Olar A
Acta Neuropathol Commun; 2018 Oct; 6(1):107. PubMed ID: 30340515
[TBL] [Abstract][Full Text] [Related]
3. Endolymphatic sac tumors. A source of morbid hearing loss in von Hippel-Lindau disease.
Manski TJ; Heffner DK; Glenn GM; Patronas NJ; Pikus AT; Katz D; Lebovics R; Sledjeski K; Choyke PL; Zbar B; Linehan WM; Oldfield EH
JAMA; 1997 May; 277(18):1461-6. PubMed ID: 9145719
[TBL] [Abstract][Full Text] [Related]
4. Characterization of endolymphatic sac tumors and von Hippel-Lindau disease in the International Endolymphatic Sac Tumor Registry.
Bausch B; Wellner U; Peyre M; Boedeker CC; Hes FJ; Anglani M; de Campos JM; Kanno H; Maher ER; Krauss T; Sansó G; Barontini M; Letizia C; Hader C; Schiavi F; Zanoletti E; Suárez C; Offergeld C; Malinoc A; Zschiedrich S; Glasker S; Bobin S; Sterkers O; Ba Huy PT; Giraud S; Links T; Eng C; Opocher G; Richard S; Neumann HP;
Head Neck; 2016 Apr; 38 Suppl 1():E673-9. PubMed ID: 25867206
[TBL] [Abstract][Full Text] [Related]
5. Differential grading of endolymphatic sac tumor extension by virtue of von Hippel-Lindau disease status.
Bambakidis NC; Megerian CA; Ratcheson RA
Otol Neurotol; 2004 Sep; 25(5):773-81. PubMed ID: 15354010
[TBL] [Abstract][Full Text] [Related]
6. Endolymphatic sac tumor with von Hippel-Lindau disease: report of a case with atypical pathology of endolymphatic sac tumor.
Yang X; Liu XS; Fang Y; Zhang XH; Zhang YK
Int J Clin Exp Pathol; 2014; 7(5):2609-14. PubMed ID: 24966975
[TBL] [Abstract][Full Text] [Related]
7. Endolymphatic sac tumors in patients with and without von Hippel-Lindau disease: the role of genetic mutation, von Hippel-Lindau protein, and hypoxia inducible factor-1alpha expression.
Jensen RL; Gillespie D; House P; Layfield L; Shelton C
J Neurosurg; 2004 Mar; 100(3):488-97. PubMed ID: 15035285
[TBL] [Abstract][Full Text] [Related]
8. Neurologic manifestations of von Hippel-Lindau disease.
Butman JA; Linehan WM; Lonser RR
JAMA; 2008 Sep; 300(11):1334-42. PubMed ID: 18799446
[TBL] [Abstract][Full Text] [Related]
9. Endolymphatic sac tumors in von Hippel-Lindau disease: report of three cases.
Codreanu CM; Duet M; Hautefort C; Wassef M; Guichard JP; Giraud S; Richard S; Roqueplo AP; Tran Ba Huy P
Otol Neurotol; 2010 Jun; 31(4):660-4. PubMed ID: 20351605
[TBL] [Abstract][Full Text] [Related]
10. Clear cell papillary renal cell carcinoma-like tumors in patients with von Hippel-Lindau disease are unrelated to sporadic clear cell papillary renal cell carcinoma.
Williamson SR; Zhang S; Eble JN; Grignon DJ; Martignoni G; Brunelli M; Wang M; Gobbo S; Baldridge LA; Cheng L
Am J Surg Pathol; 2013 Aug; 37(8):1131-9. PubMed ID: 23648463
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical expression of carbonic anhydrase 9, glucose transporter 1, and paired box 8 in von Hippel-Lindau disease-related lesions.
Chatzopoulos K; Aubry MC; Gupta S
Hum Pathol; 2022 May; 123():93-101. PubMed ID: 35196526
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological features of low-grade malignant endolymphatic sac tumors.
Wang HQ; Jie L; Shi HY
Pathol Res Pract; 2018 Mar; 214(3):431-435. PubMed ID: 29482989
[TBL] [Abstract][Full Text] [Related]
13. Surgical resection of endolymphatic sac tumors in von Hippel-Lindau disease: findings, results, and indications.
Kim HJ; Hagan M; Butman JA; Baggenstos M; Brewer C; Zalewski C; Linehan WM; Lonser RR
Laryngoscope; 2013 Feb; 123(2):477-83. PubMed ID: 23070752
[TBL] [Abstract][Full Text] [Related]
14. Management of endolymphatic sac tumors: sporadic cases and von Hippel-Lindau disease.
Nevoux J; Nowak C; Vellin JF; Lepajolec C; Sterkers O; Richard S; Bobin S
Otol Neurotol; 2014 Jun; 35(5):899-904. PubMed ID: 24662627
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterisation of sporadic endolymphatic sac tumours and comparison to von Hippel-Lindau disease-related tumours.
Schweizer L; Thierfelder F; Thomas C; Soschinski P; Kim HY; Jödicke R; Woltering N; Förster A; Teichmann D; Siewert C; Klein K; Schmid S; Nunninger M; Thomale UW; Onken J; Mühleisen H; Schittenhelm J; Tatagiba M; von Deimling A; Reuss DE; Solomon DA; Heppner FL; Koch A; Hartmann C; Staszewski O; Capper D
Neuropathol Appl Neurobiol; 2021 Oct; 47(6):756-767. PubMed ID: 34091929
[TBL] [Abstract][Full Text] [Related]
16. Endolymphatic sac tumour - a rare complication associated with von Hippel-Lindau disease.
Wozniaková M; Židlík V; Škarda J
Cesk Patol; 2023; 59(1):32-35. PubMed ID: 37072278
[TBL] [Abstract][Full Text] [Related]
17. [Endolymphatic sac tumor with von Hippel-Lindau disease: report of two cases with testing of von Hippel-Lindau gene].
Su Y; Shen WD; Wang CC; Han WJ; Liu J; Hou ZH; Song ZG; Huang DL; Han DY; Yang SM
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Nov; 48(11):913-8. PubMed ID: 24444636
[TBL] [Abstract][Full Text] [Related]
18. von Hippel-Lindau disease-related neoplasia with an emphasis on renal manifestations.
Tekin B; Erickson LA; Gupta S
Semin Diagn Pathol; 2024 Jan; 41(1):20-27. PubMed ID: 37980175
[TBL] [Abstract][Full Text] [Related]
19. Effects of VHL deficiency on endolymphatic duct and sac.
Gläsker S; Lonser RR; Tran MG; Ikejiri B; Butman JA; Zeng W; Maxwell PH; Zhuang Z; Oldfield EH; Vortmeyer AO
Cancer Res; 2005 Dec; 65(23):10847-53. PubMed ID: 16322231
[TBL] [Abstract][Full Text] [Related]
20. von Hippel-Lindau disease: surveillance strategy for endolymphatic sac tumors.
Poulsen ML; Gimsing S; Kosteljanetz M; Møller HU; Brandt CA; Thomsen C; Bisgaard ML
Genet Med; 2011 Dec; 13(12):1032-41. PubMed ID: 21912262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
